CSTL - Castle Biosciences raises 2025 revenue guidance to $310M-$320M following strong Q2 execution and test volume growth
2025-08-04 22:22:36 ET
More on Castle Biosciences
- Castle Biosciences, Inc. (CSTL) Q2 2025 Earnings Call Transcript
- Castle Biosciences Q2 2025 Earnings Preview
- Castle Biosciences, Revolution Medicines get FDA breakthrough statuses
- Seeking Alpha’s Quant Rating on Castle Biosciences
- Historical earnings data for Castle Biosciences